Changing Surgical Aortic Valve Size and Choices in the Transcatheter Aortic Valve Replacement Era

Table 1

Patient characteristics.

	Pre-TAVR era (n = 1,792)	Early TAVR era (n = 2,422)	Current-TAVR era (n = 2,231)	value
Age	67.4 (±13.6)	67.12 (±12.3)	62.4 (±12.5)	<0.001
Female gender	41% (n = 738)	39% (n = 945)	33% (n = 746)	<0.001
White race	87% (n = 1,564)	88% (n = 2121)	86% (n = 1888)	0.14
Hypertension	77% (n = 1385)	78% (n = 1899)	75% (n = 1670)	0.01
Diabetes	29% (n = 518)	33% (n = 802)	27% (n = 603)	<0.001
Lung disease (moderate or severe)	11% (n = 194)	12% (n = 285)	10% (n = 214)	<0.001
End-stage renal disease	3% (n = 52)	2% (n = 49)	2% (n = 42)	0.07
Endocarditis	5% (n = 91)	6% (n = 143)	12% (n = 264)	<0.001
Coronary artery disease	23% (n = 411)	20% (n = 489)	16% (n = 357)	<0.001
Heart failure	41% (n = 727)	45% (n = 1097)	46% (n = 1025)	<0.001
Aortic stenosis	89% (n = 1550)	88% (n = 2109)	78% (n = 1710)	<0.001
Height (cm)	170 (±11)	171 (±10)	172 (±)10	<0.001
Weight (kg)	87 (±22)	88 (±21)	90 (±21)	<0.001
STS risk of mortality (%)	2.0 (1.0–3.6)	1.8 (1.1–3.3)	1.3 (0.7–2.1)	<0.001

STS = society of thoracic surgeons; TAVR = transcatheter aortic valve replacement.